object(WP_Query)#40488 (57) {
["query"]=>
array(6) {
["posts_per_page"]=>
string(1) "5"
["cat"]=>
int(2706)
["p"]=>
string(0) ""
["suppress_filters"]=>
int(0)
["paged"]=>
int(1)
["meta_query"]=>
array(1) {
[0]=>
array(0) {
}
}
}
["query_vars"]=>
array(64) {
["posts_per_page"]=>
int(5)
["cat"]=>
int(29)
["p"]=>
int(0)
["suppress_filters"]=>
int(0)
["paged"]=>
int(1)
["meta_query"]=>
array(1) {
[0]=>
array(0) {
}
}
["error"]=>
string(0) ""
["m"]=>
string(0) ""
["post_parent"]=>
string(0) ""
["subpost"]=>
string(0) ""
["subpost_id"]=>
string(0) ""
["attachment"]=>
string(0) ""
["attachment_id"]=>
int(0)
["name"]=>
string(0) ""
["pagename"]=>
string(0) ""
["page_id"]=>
int(0)
["second"]=>
string(0) ""
["minute"]=>
string(0) ""
["hour"]=>
string(0) ""
["day"]=>
int(0)
["monthnum"]=>
int(0)
["year"]=>
int(0)
["w"]=>
int(0)
["category_name"]=>
string(14) "nota-de-prensa"
["tag"]=>
string(0) ""
["tag_id"]=>
string(0) ""
["author"]=>
string(0) ""
["author_name"]=>
string(0) ""
["feed"]=>
string(0) ""
["tb"]=>
string(0) ""
["meta_key"]=>
string(0) ""
["meta_value"]=>
string(0) ""
["preview"]=>
string(0) ""
["s"]=>
string(0) ""
["sentence"]=>
string(0) ""
["title"]=>
string(0) ""
["fields"]=>
string(0) ""
["menu_order"]=>
string(0) ""
["embed"]=>
string(0) ""
["category__in"]=>
array(0) {
}
["category__not_in"]=>
array(0) {
}
["category__and"]=>
array(0) {
}
["post__in"]=>
array(0) {
}
["post__not_in"]=>
array(0) {
}
["post_name__in"]=>
array(0) {
}
["tag__in"]=>
array(0) {
}
["tag__not_in"]=>
array(0) {
}
["tag__and"]=>
array(0) {
}
["tag_slug__in"]=>
array(0) {
}
["tag_slug__and"]=>
array(0) {
}
["post_parent__in"]=>
array(0) {
}
["post_parent__not_in"]=>
array(0) {
}
["author__in"]=>
array(0) {
}
["author__not_in"]=>
array(0) {
}
["ignore_sticky_posts"]=>
bool(false)
["cache_results"]=>
bool(true)
["update_post_term_cache"]=>
bool(true)
["lazy_load_term_meta"]=>
bool(true)
["update_post_meta_cache"]=>
bool(true)
["post_type"]=>
string(0) ""
["nopaging"]=>
bool(false)
["comments_per_page"]=>
string(2) "50"
["no_found_rows"]=>
bool(false)
["order"]=>
string(4) "DESC"
}
["tax_query"]=>
object(WP_Tax_Query)#41556 (6) {
["queries"]=>
array(1) {
[0]=>
array(5) {
["taxonomy"]=>
string(8) "category"
["terms"]=>
array(1) {
[0]=>
int(2706)
}
["field"]=>
string(7) "term_id"
["operator"]=>
string(2) "IN"
["include_children"]=>
bool(true)
}
}
["relation"]=>
string(3) "AND"
["table_aliases":protected]=>
array(1) {
[0]=>
string(21) "wp_term_relationships"
}
["queried_terms"]=>
array(1) {
["category"]=>
array(2) {
["terms"]=>
array(1) {
[0]=>
int(2706)
}
["field"]=>
string(7) "term_id"
}
}
["primary_table"]=>
string(8) "wp_posts"
["primary_id_column"]=>
string(2) "ID"
}
["meta_query"]=>
object(WP_Meta_Query)#41557 (9) {
["queries"]=>
array(0) {
}
["relation"]=>
string(3) "AND"
["meta_table"]=>
NULL
["meta_id_column"]=>
NULL
["primary_table"]=>
NULL
["primary_id_column"]=>
NULL
["table_aliases":protected]=>
array(0) {
}
["clauses":protected]=>
array(0) {
}
["has_or_relation":protected]=>
bool(false)
}
["date_query"]=>
bool(false)
["request"]=>
string(1316) "SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) JOIN wp_icl_translations wpml_translations
ON wp_posts.ID = wpml_translations.element_id
AND wpml_translations.element_type = CONCAT('post_', wp_posts.post_type) WHERE 1=1 AND (
wp_term_relationships.term_taxonomy_id IN (29)
) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish' OR wp_posts.post_status = 'acf-disabled' OR wp_posts.post_status = 'tribe-ea-success' OR wp_posts.post_status = 'tribe-ea-failed' OR wp_posts.post_status = 'tribe-ea-schedule' OR wp_posts.post_status = 'tribe-ea-pending' OR wp_posts.post_status = 'tribe-ea-draft') AND ( ( ( wpml_translations.language_code = 'es' OR 0 ) AND wp_posts.post_type IN ('post','page','attachment','wp_block','accordions','dt_portfolio','dt_gallery','dt_team','dt_testimonials','dt_slideshow','tp_accordions_pro','wp-timeline','tribe_venue','tribe_organizer','tribe_events' ) ) OR wp_posts.post_type NOT IN ('post','page','attachment','wp_block','accordions','dt_portfolio','dt_gallery','dt_team','dt_testimonials','dt_slideshow','tp_accordions_pro','wp-timeline','tribe_venue','tribe_organizer','tribe_events' ) ) GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 0, 5"
["posts"]=>
array(5) {
[0]=>
object(WP_Post)#41122 (24) {
["ID"]=>
int(33898)
["post_author"]=>
string(1) "1"
["post_date"]=>
string(19) "2021-03-18 07:07:40"
["post_date_gmt"]=>
string(19) "2021-03-18 07:07:40"
["post_content"]=>
string(0) ""
["post_title"]=>
string(102) "Sylentis (Grupo PharmaMar) inicia un ensayo clínico de fase I con SYL1801 para enfermedades de retina"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(99) "sylentis-grupo-pharmamar-inicia-un-ensayo-clinico-de-fase-i-con-syl1801-para-enfermedades-de-retina"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2021-03-18 07:07:40"
["post_modified_gmt"]=>
string(19) "2021-03-18 07:07:40"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(30) "https://pharmamar.com/?p=33898"
["menu_order"]=>
int(0)
["post_type"]=>
string(4) "post"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
[1]=>
object(WP_Post)#41555 (24) {
["ID"]=>
int(33783)
["post_author"]=>
string(1) "1"
["post_date"]=>
string(19) "2021-03-04 08:25:34"
["post_date_gmt"]=>
string(19) "2021-03-04 08:25:34"
["post_content"]=>
string(0) ""
["post_title"]=>
string(143) "La FDA autoriza a Sylentis (Grupo PharmaMar) el inicio del ensayo de fase III con tivanisirán para el tratamiento de la enfermedad de ojo seco"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(140) "la-fda-autoriza-a-sylentis-grupo-pharmamar-el-inicio-del-ensayo-de-fase-iii-con-tivanisiran-para-el-tratamiento-de-la-enfermedad-de-ojo-seco"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2021-03-04 08:25:34"
["post_modified_gmt"]=>
string(19) "2021-03-04 08:25:34"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(30) "https://pharmamar.com/?p=33783"
["menu_order"]=>
int(0)
["post_type"]=>
string(4) "post"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
[2]=>
object(WP_Post)#97872 (24) {
["ID"]=>
int(33773)
["post_author"]=>
string(1) "1"
["post_date"]=>
string(19) "2021-03-01 08:32:14"
["post_date_gmt"]=>
string(19) "2021-03-01 08:32:14"
["post_content"]=>
string(0) ""
["post_title"]=>
string(107) "PharmaMar firma un nuevo acuerdo con Adium para comercializar Zepzelca® (lurbinectedina) en Latinoamérica"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(102) "pharmamar-firma-un-nuevo-acuerdo-con-adium-para-comercializar-zepzelca-lurbinectedina-en-latinoamerica"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2021-03-01 08:32:14"
["post_modified_gmt"]=>
string(19) "2021-03-01 08:32:14"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(30) "https://pharmamar.com/?p=33773"
["menu_order"]=>
int(0)
["post_type"]=>
string(4) "post"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
[3]=>
object(WP_Post)#97871 (24) {
["ID"]=>
int(33725)
["post_author"]=>
string(1) "1"
["post_date"]=>
string(19) "2021-02-26 16:46:57"
["post_date_gmt"]=>
string(19) "2021-02-26 16:46:57"
["post_content"]=>
string(0) ""
["post_title"]=>
string(86) "El Grupo PharmaMar presenta en el ejercicio 2020 los mejores resultados de su historia"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(86) "el-grupo-pharmamar-presenta-en-el-ejercicio-2020-los-mejores-resultados-de-su-historia"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2021-02-26 16:46:57"
["post_modified_gmt"]=>
string(19) "2021-02-26 16:46:57"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(30) "https://pharmamar.com/?p=33725"
["menu_order"]=>
int(0)
["post_type"]=>
string(4) "post"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
[4]=>
object(WP_Post)#97869 (24) {
["ID"]=>
int(33691)
["post_author"]=>
string(1) "1"
["post_date"]=>
string(19) "2021-02-17 10:15:22"
["post_date_gmt"]=>
string(19) "2021-02-17 10:15:22"
["post_content"]=>
string(0) ""
["post_title"]=>
string(159) "Reino Unido aprueba el inicio del ensayo clínico de fase III NEPTUNO con Aplidin® (plitidepsina), de PharmaMar, para el tratamiento de pacientes con COVID-19"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(152) "reino-unido-aprueba-el-inicio-del-ensayo-clinico-de-fase-iii-neptuno-con-aplidin-plitidepsina-de-pharmamar-para-el-tratamiento-de-pacientes-con-covid-19"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2021-02-17 10:15:22"
["post_modified_gmt"]=>
string(19) "2021-02-17 10:15:22"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(30) "https://pharmamar.com/?p=33691"
["menu_order"]=>
int(0)
["post_type"]=>
string(4) "post"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
}
["post_count"]=>
int(5)
["current_post"]=>
int(-1)
["in_the_loop"]=>
bool(false)
["post"]=>
object(WP_Post)#41122 (24) {
["ID"]=>
int(33898)
["post_author"]=>
string(1) "1"
["post_date"]=>
string(19) "2021-03-18 07:07:40"
["post_date_gmt"]=>
string(19) "2021-03-18 07:07:40"
["post_content"]=>
string(0) ""
["post_title"]=>
string(102) "Sylentis (Grupo PharmaMar) inicia un ensayo clínico de fase I con SYL1801 para enfermedades de retina"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(99) "sylentis-grupo-pharmamar-inicia-un-ensayo-clinico-de-fase-i-con-syl1801-para-enfermedades-de-retina"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2021-03-18 07:07:40"
["post_modified_gmt"]=>
string(19) "2021-03-18 07:07:40"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(30) "https://pharmamar.com/?p=33898"
["menu_order"]=>
int(0)
["post_type"]=>
string(4) "post"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
["comment_count"]=>
int(0)
["current_comment"]=>
int(-1)
["found_posts"]=>
string(3) "436"
["max_num_pages"]=>
float(88)
["max_num_comment_pages"]=>
int(0)
["is_single"]=>
bool(false)
["is_preview"]=>
bool(false)
["is_page"]=>
bool(false)
["is_archive"]=>
bool(true)
["is_date"]=>
bool(false)
["is_year"]=>
bool(false)
["is_month"]=>
bool(false)
["is_day"]=>
bool(false)
["is_time"]=>
bool(false)
["is_author"]=>
bool(false)
["is_category"]=>
bool(true)
["is_tag"]=>
bool(false)
["is_tax"]=>
bool(false)
["is_search"]=>
bool(false)
["is_feed"]=>
bool(false)
["is_comment_feed"]=>
bool(false)
["is_trackback"]=>
bool(false)
["is_home"]=>
bool(false)
["is_privacy_policy"]=>
bool(false)
["is_404"]=>
bool(false)
["is_embed"]=>
bool(false)
["is_paged"]=>
bool(false)
["is_admin"]=>
bool(false)
["is_attachment"]=>
bool(false)
["is_singular"]=>
bool(false)
["is_robots"]=>
bool(false)
["is_posts_page"]=>
bool(false)
["is_post_type_archive"]=>
bool(false)
["query_vars_hash":"WP_Query":private]=>
string(32) "3e1ffe7d212177d6b89e779503c0acf9"
["query_vars_changed":"WP_Query":private]=>
bool(false)
["thumbnails_cached"]=>
bool(false)
["stopwords":"WP_Query":private]=>
NULL
["compat_fields":"WP_Query":private]=>
array(2) {
[0]=>
string(15) "query_vars_hash"
[1]=>
string(18) "query_vars_changed"
}
["compat_methods":"WP_Query":private]=>
array(2) {
[0]=>
string(16) "init_query_flags"
[1]=>
string(15) "parse_tax_query"
}
["tribe_is_event"]=>
bool(false)
["tribe_is_multi_posttype"]=>
bool(false)
["tribe_is_event_category"]=>
bool(false)
["tribe_is_event_venue"]=>
bool(false)
["tribe_is_event_organizer"]=>
bool(false)
["tribe_is_event_query"]=>
bool(false)
["tribe_is_past"]=>
bool(false)
}
